miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells
Authors
Keywords
miR-33a, β-Catenin, Chemoresistance, Pancreatic cancer
Journal
TUMOR BIOLOGY
Volume 36, Issue 12, Pages 9395-9403
Publisher
Springer Nature
Online
2015-06-25
DOI
10.1007/s13277-015-3679-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway
- (2015) Wei Xu et al. CANCER LETTERS
- Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma
- (2014) Sayantani Sarkar et al. ENDOCRINE-RELATED CANCER
- miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
- (2014) Yong Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Novel Regulatory Mechanism of Pim-3 Kinase Stability and Its Involvement in Pancreatic Cancer Progression
- (2013) F. Zhang et al. MOLECULAR CANCER RESEARCH
- XB130, a New Adaptor Protein, Regulates Expression of Tumor Suppressive MicroRNAs in Cancer Cells
- (2013) Hiroki Takeshita et al. PLoS One
- Aflatoxin B1 Negatively Regulates Wnt/β-Catenin Signaling Pathway through Activating miR-33a
- (2013) Yi Fang et al. PLoS One
- Mir-33 regulates cell proliferation and cell cycle progression
- (2012) Daniel Cirera-Salinas et al. CELL CYCLE
- Silencing of XB130 Is Associated with Both the Prognosis and Chemosensitivity of Gastric Cancer
- (2012) Min Shi et al. PLoS One
- MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
- (2011) A. F. Ibrahim et al. CANCER RESEARCH
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- The proto-oncogene Pim-1 is a target of miR-33a
- (2011) M Thomas et al. ONCOGENE
- miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
- (2011) A. Davalos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
- (2010) S. H. Najafi-Shoushtari et al. SCIENCE
- MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
- (2010) K. J. Rayner et al. SCIENCE
- Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibition
- (2009) Qingqu Guo et al. BIOCHEMICAL PHARMACOLOGY
- The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
- (2009) M Flahaut et al. ONCOGENE
- Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions
- (2009) Roland Andersson et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started